Mumbia, India

Kasim Mookhtiar




Average Co-Inventor Count = 10.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Location History:

  • Mumbia, IN (2022)
  • Mumbai, IN (2021 - 2024)

Company Filing History:


Years Active: 2021-2024

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):

Title: Innovations of Kasim Mookhtiar

Introduction

Kasim Mookhtiar is a notable inventor based in Mumbai, India. He has made significant contributions to the field of medicinal chemistry, particularly through his innovative work on tricyclic compounds. With a total of 3 patents to his name, Mookhtiar is recognized for his advancements in pharmaceutical applications.

Latest Patents

One of Mookhtiar's latest patents focuses on "Tricyclic compounds, compositions and medicinal applications thereof." This patent discloses a series of tricyclic compounds, including their tautomers, polymorphs, stereoisomers, prodrugs, solvates, and pharmaceutically acceptable salts. The compounds are designed to treat conditions mediated by adenosine receptor (AR) activity. The patent also outlines the preparation processes for these compounds, which are useful in the treatment, prevention, or suppression of diseases that may benefit from adenosine receptor antagonism.

Career Highlights

Kasim Mookhtiar is currently associated with Impetis Biosciences Limited, where he continues to innovate in the field of drug development. His work has the potential to impact various therapeutic areas, enhancing treatment options for patients.

Collaborations

Mookhtiar collaborates with esteemed colleagues such as Bheemashankar A Kulkarni and Sujay Basu, contributing to a dynamic research environment that fosters innovation.

Conclusion

Kasim Mookhtiar's contributions to medicinal chemistry through his patents on tricyclic compounds highlight his role as a significant inventor in the pharmaceutical industry. His work not only advances scientific knowledge but also holds promise for improving patient care.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…